<p>An objective of the present invention is to provide a suppressant for cerebral infarction occurred after long-term ischemia associated with actual cerebral infarction, and has fewer side effects. The cerebral infarction suppressant of the present invention is characterized in comprising an anti-HMGB1 monoclonal antibody as an active ingredient.</p>
申请公布号
EP1946774(B1)
申请公布日期
2013.12.04
申请号
EP20060811724
申请日期
2006.10.13
申请人
NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY;EHIME UNIVERSITY
